Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Endometrial Neoplasms × aflibercept × 30 days × Clear all

Sponsor

Conditions

Melanoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

pembrolizumab 14 Specimen Handling 12 Paclitaxel 11 Carboplatin 11 Magnetic Resonance Spectroscopy 8 Fulvestrant 6 Biopsy 6 lenvatinib 5 Taxes 5 Bevacizumab 5 olaparib 4 trastuzumab deruxtecan 3 X-Rays 3 Oxaliplatin 3 Letrozole 3 Doxorubicin 3 Cisplatin 3 palbociclib 2 ceralasertib 2 abemaciclib 2 Phantoms, Imaging 2 Observation 2 Nivolumab 2 Megestrol Acetate 2 Medroxyprogesterone Acetate 2 Leucovorin 2 Irinotecan 2 Immunoglobulin G 2 Gemcitabine 2 Fluorouracil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡